Rather than an unrestricted endorsement of GLP-1 RAs for the treatment of psoriasis even in patients with overweight/obesity who are candidates for these drugs, the authors stated, definitive conclusions await larger randomized trials. However, Blauvelt pointed out that these therapies are attractive in patients who are overweight with psoriasis, even if their precise role is still being explored
A separate research letter published in JAMA identified an average percentage of days covered (PDC) of 54% in patients with obesity and without diabetes 12 months after GLP-1 RA initiation
Other Ingredients: Organic Cassava Syrup, Organic Glycerin, Phosphatidylcholine, Malic Acid, Organic Orange Oil
But its benefits for any use on the skin are poorly studied and unclear
Sandborn WJ, Peyrin-Biroulet L, Zhang J, Chiorean M, Vermeire S, Lee SD, et al
A product passesonly when all measured metals fall below USP limits;any result exceeding those limits is considered afail